Home/Filings/4/0001415889-24-024183
4//SEC Filing

Jin David 4

Accession 0001415889-24-024183

CIK 0001429260other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:15 PM ET

Size

5.2 KB

Accession

0001415889-24-024183

Insider Transaction Report

Form 4
Period: 2024-10-01
Jin David
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.001

    2024-10-01$1.23/sh+2,625$3,224240,893 total
Footnotes (2)
  • [F1]The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]Total holdings include 230,000 shares underlying deferred restricted stock units.

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeother

Related Parties

1
  • filerCIK 0001930732

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:15 PM ET
Size
5.2 KB